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Abstract
Chronic viral infections lead to CD8+ T cell exhaustion, characterized by impaired cytokine secretion. Presence of the
immune-regulatory cytokine IL-10 promotes chronicity of Lymphocytic Choriomeningitis Virus (LCMV) Clone 13 infection,
while absence of IL-10/IL-10R signaling early during infection results in viral clearance and higher percentages and numbers
of antiviral, cytokine producing T cells. IL-10 is produced by several cell types during LCMV infection but it is currently
unclear which cellular sources are responsible for induction of viral chronicity. Here, we demonstrate that although dendritic
cells produce IL-10 and overall IL-10 mRNA levels decrease significantly in absence of CD11c+ cells, absence of IL-10
produced by CD11c+ cells failed to improve the LCMV-specific T cell response and control of LCMV infection. Similarly, NK
cell specific IL-10 deficiency had no positive impact on the LCMV-specific T cell response or viral control, even though high
percentages of NK cells produced IL-10 at early time points after infection. Interestingly, we found markedly improved T cell
responses and clearance of normally chronic LCMV Clone 13 infection when either myeloid cells or T cells lacked IL-10
production and mice depleted of monocytes/macrophages or CD4+ T cells exhibited reduced overall levels of IL-10 mRNA.
These data suggest that the decision whether LCMV infection becomes chronic or can be cleared critically depends on early
CD4+ T cell and monocyte/macrophage produced IL-10.
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Introduction
The functional down regulation of antiviral T cells, also termed T
cell exhaustion, is a major hurdle inhibiting the control or even
clearance of chronic infections. T cell exhaustion is characterized by a
gradual loss of cytokine producing antiviral CD8+ T cells [1]. The
host-derived anti-inflammatory cytokine IL-10 is an important player
in driving T cell exhaustion and viral chronicity in LCMV Clone 13
infected mice [2,3], a commonly used murine model for chronic viral
infections. Elevated IL-10 levels were also found to correlate with HIV
replication in humans and transition to chronicity during HBV and
HCV infection [4,5,6]. Since disruption of IL-10 receptor signaling
enhances CD8+ T cell effector functions not only after LCMV
infection [2,3], but also in case of HIV-, HBV- or HCV-specific T
cells [6,7,8,9], interference with IL-10 signaling is currently proposed
as a target for immune-based interventions during chronic viral
infections.
IL-10 is expressed during several persistent infections. It may on
the one hand favor viral chronicity by suppressing the antiviral
immune response, but on the other hand also protect the host from
immunopathology [10,11]. IL-10 acts mainly by modulating the
expression of proinflammatory cytokines and chemokines, by
modulating the function of antigen presenting cells (i.e. down-
regulating for example the expression of MHCI, MHCII, B7-1
and B7-2) and by directly or indirectly suppressing proliferation,
functional differentiation and effector activity of antiviral T cells
[10,11]. Suppression of the antiviral immune response through IL-
10 is a strategy actively exploited by herpes- and poxviruses which
can encode viral IL-10 homologues to weaken the antiviral
immune response [12]. Accordingly, rhesus macaques infected
with rhesus CMV deficient for rhcmvIL-10 exhibit a T and B cell
response of higher quality and quantity [13].
In addition, genetic polymorphisms in the IL-10 promoter are
associated with decreased IL-10 production, leading to enhanced
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control of HCV, HBV, HIV and Epstein Barr Virus (EBV)
[14,15,16,17,18]. Despite the advantages of more effective immune
responses in absence of IL-10, this may come at the expense of
immunopathology [19,20,21]. It is currently unclear which cellular
source(s) of IL-10 are decisive in promoting chronicity of high dose
LCMV infection. Several cell populations have been reported to
produce IL-10 after LCMV infection: LCMV specific CD4+ T cells
secrete IL-10 on day 5 post infection [22], IL-10 mRNA is
upregulated in dendritic cells (DCs), B cells, macrophages, CD4+
and CD8+ T cells on day 9 post infection [2] and purified CD4+ T
cells and DCs produce IL-10 upon LCMV infection of splenocytes
in vitro [3]. Furthermore, high percentages of DCs and macrophag-
es, but also B cells, CD4+ and CD8+ T cells produce IL-10 nine and
thirty days after Clone 13 infection when assessed in IL-10 reporter
(VertX) mice [23]. Significant IL-10 production was found mainly
in CD82 DCs and IL-10 serum protein levels were decreased in
mice with selective IL-10 deficiency in CD11c+ cells [24]. In
contrast, the IL-10 levels remained unaffected in B cell or T cell
specific IL-10 knockouts on day 10 post infection [24].
Importantly and surprisingly, functional data evaluating the
consequences of cell-specific IL-10 deficiency are lacking. It is
conceivable that IL-10 is not primarily acting on a systemic level
but in a microenvironment where IL-10 secreting cells and the
immediate surrounding target cells are spatially and temporarily
connected. Therefore, it is of great importance to identify the
biologically relevant IL-10 producing cell populations responsible
for impairment of LCMV-specific T cell immunity and conse-
quently viral chronicity.
We show here that even though DCs are a major source of IL-10,
specific IL-10 deficiency in DCs neither leads to functional
improvement of the LCMV-specific T cell response nor does it
prevent viral chronicity. Likewise, even though high percentages of
NK cells produced IL-10 early after infection, NK cell specific IL-10
knockout mice were not able to clear LCMV and exhibited exhaus-
ted T cells. However, depletion of CD4+ T cells or monocytes/
macrophages resulted in decreased overall amounts of IL-10 mRNA
and selective IL-10 deficiency in T cells or myeloid cells prevented
viral chronicity, identifying CD4+ T cells and monocytes/macro-
phages as the decisive IL-10 source responsible for suppressing T cell
immunity and viral control during high dose LCMV infection.
Results
Kinetics of IL-10 production after high dose infection
with LCMV Clone 13
To evaluate the timing when IL-10 determines about persis-
tence or clearance of LCMV, the kinetics of viral titers were
compared in C57BL/6 and Il-102/2 mice early after infection
(Figure 1A and Figure S1A–E). Interestingly, viral titers were
comparable in all tested organs in both mouse strains until day 5/6
post infection. Afterwards, titers gradually decreased in Il-102/2
mice before the virus was cleared around day 10 post infection,
whereas the titers remained high in C57BL/6 mice. Next, the
question when IL-10R signaling is crucial to establish chronicity
was addressed by starting IL-10R blockade at different time points
after Clone 13 infection (Figure 1B). Most mice that were treated
with aIL-10R antibodies on day 0 and 1 succeeded in clearing
LCMV Clone 13, while the groups where aIL-10R treatment was
started on day 2 or 3 developed severe immunopathology, which is
often observed in situations of concomitant presence of high
amount of antigen in presence of high numbers of functional T
cells [25,26]. High viral titers were observed in the group where
aIL-10R treatment was started on day 4 post infection, com-
parable to the untreated group. Similar observations were made in
kidney, liver and lung (data not shown). Thus, IL-10 acts during
the first two days after infection to prevent immunopathology and
to establish viral chronicity.
Many cell populations are able to produce IL-10 early
after high dose LCMV Clone 13 infection
To evaluate the dynamics of IL-10 production within the first
days after LCMV infection, IL-10 mRNA levels were measured
with daily intervals for the first 4 days. IL-10 mRNA was
maximally induced during the first two days after infection and
decreased afterwards in spleen (Figure 1C), lung (Figure S1G) and
liver (Figure S1I). In the mesenteric lymph node IL-10 mRNA
expression peaked on day 3 post infection (Figure S1H).
Quantification of IL-10 mRNA expression revealed that the
highest amounts of IL-10 mRNA were expressed on day 2 post
infection in the spleen (Figure S1F). This prompted us to
concentrate further analysis of IL-10 producing cell populations
on spleen of day two post infection. FACS sorting of various cell
populations and subsequent measurement of IL-10 mRNA levels
by qPCR revealed that CD4+ T cells, CD8+ T cells, CD25+ CD4+
T cells, pDCs, CD82 DCs, neutrophils, macrophages and NKT
cells upregulated IL-10 mRNA compared to naı¨ve C57BL/6
splenocytes (Figure 1D). However, only in purified NK cells the
level of IL-10 mRNA increased to levels above those present in
unsorted splenocytes. On day 5 post infection, IL-10 mRNA could
no longer be detected in NK and NKT cells, whereas expression
persisted in macrophages (Figure 1E).
Consistent with these data, analyses in TIGER IL-10-GFP
reporter mice revealed around 10% of NK cells expressing GFP,
while only between 0.5 and 2% of the NKT cells, DCs, CD4+ and
CD8+ T cells were GFP+ on day 2 post infection (Figure S2). On
day 5 post infection around 6% of the NK cells and 0.4–2% of the
NKT cells, DCs, CD4+ and CD8+ T cells were GFP+.
Consecutive waves of IL-10 production by different cell
populations
In order to assess cell populations producing high amounts of
IL-10 on a population level instead of on a per cell basis, the
percentages of different cell populations of the splenocytes were
determined on days 2 and 5 post infection. NK cells constituted
Author Summary
Chronic viral infections like Hepatitis B and C Virus (HBV
and HCV) and Human Immunodeficiency Virus (HIV) in
humans affect more than 500 million people worldwide.
While a robust T cell response is a hallmark of many acute
infections one hurdle inhibiting the clearance of chronic
viral infections is that the immune-suppressive cytokine IL-
10 modulates the virus-host balance towards induction of
T cell dysfunction. IL-10 is produced by several cell types
during chronic Lymphocytic Choriomeningitis Virus
(LCMV) infection but it is currently unclear which cellular
sources are responsible to promote viral chronicity. Here,
we demonstrate that T cell responses improved markedly,
and that normally chronic LCMV Clone 13 infection could
be cleared when either myeloid cells or T cells lacked IL-10
production. Furthermore, mice depleted of monocytes/
macrophages or CD4+ T cells exhibited reduced overall
levels of IL-10 mRNA. These data suggest that the decision
whether LCMV infection becomes chronic or can be
cleared critically depends on CD4+ T cell and monocyte/
macrophage produced IL-10 early during the establish-
ment of viral chronicity.
IL-10 Source Supporting LCMV Chronicity
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0.9660.23% of the splenocytes on day 2 and 1.8160.13% on
day 5 post infection while NKT cells accounted for 0.1160.05%
on day 2 and 0.260.03% on day 5. B cells were present at
28.764.3% on day 2 and at 56.662.18% on day 5 while CD4+ T
cells constituted 7.9261.47% on day 2 and 8.2661.35% on day 5
and CD8+ T cells accounted for 4.9761.26% on day 2 and
11.1760.87% on day 5. DCs represented 0.7560.15% on day 2
and 0.9260.18% on day 5 while F4/80+ macrophages formed
1.4360.55% on day 2 and 3.4260.17% on day 5 (data not
shown). To integrate the different abundance of IL-10 producing
cell populations, C57BL/6 mice were depleted of specific cell
populations and overall IL-10 mRNA levels in splenocytes were
compared to undepleted control mice on day 2 post infection.
Depletion of neutrophils, CD4+ or CD8+ T cells, CD25+ T cells
and B cells did not lead to a decrease in the overall IL-10 mRNA
levels (Figure 2A and B). Unexpectedly, depletion of NK-like cells
did not result in overall decreased IL-10 mRNA levels (Figure 2B)
despite the high IL-10 mRNA expression level in purified cells
(Figure 1D). In contrast, depletion of CD11c+ cells (DCs, alveolar
macrophages and marginal zone macrophages; Figure 2C) led
to significantly decreased overall IL-10 mRNA expression. In
addition, clodronate liposome meditated depletion of splenic (red
pulp, marginal zone and metallophilic [27], but not CD68+ [28])
macrophages led to decreased expression of IL-10 mRNA
compared to undepleted controls (Figure 2D). Thus, DCs and
monocytes/macrophages account for a significant proportion of
IL-10 mRNA on day 2 post infection. Analysis on day 5 post
infection revealed that CD8+ T cell depleted mice expressed
similar overall levels of IL-10 mRNA as undepleted controls
(Figure 2E), while CD4+ T cell depleted, clodronate liposome
treated mice and DC specific IL-10 knockout mice (Il-10fl/
flxCD11c-Cre+ mice) exhibited reduced levels (Figure 2F–H). We
chose to use Il-10fl/flxCD11c-Cre+ mice instead of DT-treated
CD11c-DTR+ mice for the analysis of IL-10 mRNA levels on day 5
post infection due to the described toxicity of DT treatment for 5
days [29] and to avoid secondary consequences on viral control
which might be caused due to inefficient T cell priming in absence
of DCs [30].
Thus, DCs and monocytes/macrophages account for a first
wave of IL-10 production, followed by a second wave of IL-10
Figure 1. Virus titers in presence and absence of IL-10 and IL-10 mRNA expression levels. (A) C57BL/6 and Il-102/2 mice were infected
with LCMV Clone 13 and virus titers were determined in the spleen at the indicated time points. Several time points were reconfirmed in additional
experiments. (B) C57BL/6 mice were infected with Clone 13 and treated with aIL-10R at the indicated time point or left untreated. The treatment was
repeated in all groups except the untreated group on day 5 post infection. Virus titers in the spleen were analyzed on day 12 post infection. The
numbers indicate the number of mice that had to be killed due to immunopathological disease symptoms during the course of the infection. One
representative of two experiments is shown. (C) C57BL/6 mice were infected with Clone 13. RNA was extracted from spleen at the indicated time
points. cDNA was subjected to IL-10 qPCR. The relative expression was normalized to b-actin. The fold induction relative to the levels in naı¨ve C57BL/
6 is depicted. A naı¨ve Il-102/2 mouse served as negative control. Each symbol represents one mouse. One representative of two experiments is
shown. (D+E) Splenocytes from C57BL/6 mice were FACS sorted for the indicated cell populations on (D) day 2 and (E) day 5 post infection with LCMV
Clone 13 and IL-10 mRNA levels were measured by qPCR. The relative expression was normalized to b-actin. The fold induction relative to the levels in
naı¨ve C57BL/6 is shown. Three samples of pooled splenocytes from two mice were analyzed per experiment. A summary of 10 individual experiments
with variable repetitions of specific cell types is shown. n.d.: not detectable.
doi:10.1371/journal.ppat.1003735.g001
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PLOS Pathogens | www.plospathogens.org 3 November 2013 | Volume 9 | Issue 11 | e1003735
production by DCs, CD4+ T cells and monocytes/macrophages
on day 5 post infection.
Mast cell, B cell, NK cell and CD11c+ cell produced IL-10 is
not required to promote T cell exhaustion and viral
chronicity
Even though different cell populations expressed IL-10 at
different time points after LCMV infection, it is unclear if IL-10
secreted by any particular cell population is promoting viral
chronicity and T cell exhaustion. To assess the effects of cell-type
specific IL-10 deficiency on T cell effector functions and the
resulting decision between chronicity versus clearance of the viral
infection, we made use of conditional IL-10 knockout mice. These
mice feature a floxed IL-10 gene and express the Cre recombinase
under control of different cell-type specific promoters. While
Il-102/2 mice were able to clear LCMV Clone 13 infection by
day 12, Il-10fl/flxM5-Cre+ mice, harboring a mast cell specific IL-
10 deficiency, were unable to control the infection akin their Cre
negative littermate controls and C57BL/6 mice (Figure S3A–D).
Single target amplification of the Il-10 locus of single FACS sorted
mast cells from Il-10fl/flxM5-Cre+ mice previously confirmed that
selectively the deleted version, but never the loxP-flanked product
was amplified, while the opposite was true for non-mast cells and
Cre-negative control cells [31].
We chose to assess T cell functionality by assessing TNF-a
production as a surrogate for polyfunctionality of T cells as it is
well established that virtually all TNF-a producing T cells are co-
producers of IFN-c [32,33] (representative raw data are depicted
in Figure S4). We decided to use stimulation with gp33–41 (gp33)
as the frequencies of cytokine producing CD8+ T cells are higher
than after stimulation with np396–404 and therefore not as prone
to unspecific variances close to the detection limit (as the
percentage of TNF-a producing T cells is fairly low in exhausted
T cells; [34]). TNF-a production by antiviral CD4+ T cells was
measured after stimulation with the viral peptide gp61–80 (p13).
In line with the fact that mast cell derived IL-10 was dispensable
for the development of a chronic infection, the antiviral CD8+ and
CD4+ T cells of Il-10fl/flxM5-Cre+ mice showed an exhausted
Figure 2. IL-10 mRNA levels on day 2 and 5 post infection after depletion of selective cell populations. (A–D) IL-10 mRNA levels in the
spleen were determined on day 2 post LCMV Clone 13 infection by qPCR. (A) C57BL/6 mice were aLy6G, aCD4, aCD20 or aCD8 depleted or left
untreated. (B) C57BL/6 mice were aNK1.1 or aCD25 depleted or left untreated. NK depletion: One representative of three experiments depicted. (C)
CD11c-DTR+ and CD11c-DTR2 mice were treated with diphtheria toxin. One representative of two experiments is shown. (D) C57BL/6 mice were
treated with clodronate containing liposomes or empty control liposomes. One representative of three experiments is shown. (E–H) IL-10 mRNA
levels in the spleen were determined on day 5 post infection with LCMV Clone 13 by qPCR. C57BL/6 mice were (E) aCD8 or (F) aCD4 depleted or left
untreated. (G) Il-10fl/flxCD11c-Cre+ and Il-10fl/flxCD11c-Cre2 mice. (H) C57BL/6 mice were treated with clodronate containing liposomes or empty
control liposomes. The relative IL-10 expression was normalized to b-actin. The fold induction relative to the levels in naı¨ve C57BL/6 is shown. A naı¨ve
Il-102/2 mouse served as negative control. Each symbol represents one mouse. One representative of two is shown for each experiment.
doi:10.1371/journal.ppat.1003735.g002
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phenotype in lung and spleen (identified by reduced TNF-a
production) unlike Il-102/2 mice (Figure S3E–J). In addition, the
number of IFN-c+ CD8+ T cells was not significantly different in
Il-10fl/flxM5-Cre+ and Il-10fl/flxM5-Cre2 mice in the spleen (Figure
S5A). Thus, mast cell specific IL-10 deficiency neither improves T
cell mediated cytokine production nor virus control.
Il-10fl/flxCD19-Cre+ mice were previously shown to delete IL-10
specifically in B cells and not or only insignificantly in splenic
CD3+ T cells, peritoneal macrophages and tail biopsies [35].
Similar to mast cell specific IL-10 knockout mice, B cell specific
IL-10 knockout mice displayed comparable virus titers (Figure 3A–
D) and TNF-a production by CD4+ and CD8+ T cells in spleens
and lungs to their Cre negative littermates and to C57BL/6
controls (Figure 3E–J; FACS plots of a representative staining are
depicted in Figure S4). In addition, the number of IFN-c+ CD8+ T
cells was similar Il-10fl/flxCD19-Cre+ and Il-10fl/flxCD19-Cre2 mice
in the spleen (Figure S5B; FACS plots of a representative staining
are depicted in Figure S4).
NK cells produced high amounts of IL-10 on a per cell basis on
day 2 post infection (Figure 1D). To examine if NK cell derived
IL-10 is decisive for Clone 13 infection to become chronic, Il-10fl/
flxNcr1-Cre+ mice were derived from Il-10fl/fl and Ncr1-Cre+ mice.
This mouse strain deleted the Il-10 gene in 63% of the NK cells
(Figure S6A). Il-10fl/flxNcr1-Cre+ mice were infected with Clone 13
and analyzed on day 12 post infection. In agreement with the
observation that depletion of NK-like cells did not influence total
IL-10 mRNA levels (Figure 2B), Il-10fl/flxNcr1-Cre+ mice displayed
high virus titers like their Cre negative littermates and like
C57BL/6 mice (Figure 4A–D). In addition, the antiviral CD8+
and CD4+ T cells showed both low percentages and total numbers
of TNF-a+ cells and were as exhausted as in the Cre negative
littermate controls and as in C57BL/6 mice (Figure 4E–J).
Furthermore, the number of IFN-c+ CD8+ T cells was similar in
Il-10fl/flxNcr1-Cre+ and Il-10fl/flxNcr1-Cre2 mice in the spleen
(Figure S5C). Thus, the high amount of IL-10 mRNA on a per cell
basis did not translate into a biologically relevant role of NK cell-
derived IL-10 for the decision between chronicity and clearance of
LCMV infection.
CD82 DCs and pDCs expressed IL-10 mRNA on day 2 post
infection (Figure 1D). In accordance with the literature [24],
absence of CD11c+ cell-derived IL-10 resulted in strongly
decreased overall IL-10 mRNA levels on day 2 and 5 post
infection in the spleen (Figure 2C and G). Il-10fl/flxCD11c-Cre+
mice proved to delete the Il-10 gene specifically in DCs (Figure
S6B). Unexpectedly, LCMV Clone 13 infection was not
controlled in Il-10fl/flxCD11c-Cre+ mice (Figure 5A–D) and
resulted in low percentages and total numbers of TNF-a
producing antiviral CD8+ and CD4+ T cells comparable to
littermate and C57BL/6 controls (Figure 5E–H). Furthermore,
the number of IFN-c+ CD8+ T cells was similar in the spleens of
Il-10fl/flxNcr1-Cre+ and Il-10fl/flxNcr1-Cre2 mice (Figure S5D).
Thus, even though CD11c+ cells contribute substantially to
the early overall IL-10 production during LCMV infection
(Figure 1D, 2C and G), CD11c+ cell derived IL-10 does not seem
to play a role for the outcome of the infection and the quality of
the antiviral T cell response.
Monocyte/macrophage derived IL-10 drives chronicity of
LCMV infection
As neutrophils and macrophages produce IL-10 on day 2 and 5
post infection (Figure 1D and E) and as monocyte/macrophage
depletion reduced the overall IL-10 mRNA levels (Figure 2D and
H), Il-10fl/flxLysM-Cre+ mice, in which selectively myeloid cells
lack IL-10 production, were infected with Clone 13. Il-10fl/
flxLysM-Cre+ mice were previously shown to delete IL-10
specifically in neutrophils and macrophages and not or only
insignificantly in dendritic cells, T cells and B cells [36].
Interestingly, 50% of the Il-10fl/flxLysM-Cre+ mice succeeded in
significantly reducing LCMV Clone 13 titers like Il-102/2 mice
and unlike the Cre negative littermates and C57BL/6 mice
(Figure 6A–D). In line with this, a higher percentage and total
number of TNF-a producing T cells was observed in the spleens
and lungs of Il-10fl/flxLysM-Cre+ mice which could control the
infection compared to Cre negative littermate controls, the Il-10fl/
flxLysM-Cre+ mice which could not control the infection and
C57BL/6 mice (Figure 6E–J). In addition, the number of IFN-c+
CD8+ T cells was higher in the Il-10fl/flxLysM-Cre+ which could
reduce the virus load than in Il-10fl/flxLysM-Cre2 mice in the
spleen (Figure S5E). Thus, myeloid cell derived IL-10 contributes
significantly to the biologically relevant effects of IL-10 without
accounting for the full phenotype. As depletion of monocytes/
macrophages decreased the levels of IL-10 mRNA on days 2 and 5
post infection, while aLy6G depletion failed to do so (Figure 2A), it
is likely that monocytes/macrophages are the relevant IL-10
source rather than neutrophils.
T cell derived IL-10 drives chronicity of the LCMV
infection
Based on the finding that CD4+ and CD8+ T cells produced IL-
10 after Clone 13 infection (Figure 1D) and that CD4+ T cell
depletion decreased IL-10 mRNA levels on day 5 post infection
(Figure 2F), we investigated if T cell derived IL-10 complements
macrophage derived IL-10 to exert it’s biological effects. Il-10fl/
flxCD4-Cre+ mice were shown previously to delete the Il-10 gene
specifically in T cells [37]. Interestingly, almost all Il-10fl/flxCD4-
Cre+ mice succeeded in clearing Clone 13 within 12 days
comparable to Il-102/2 mice and opposed to Cre negative
littermate controls and C57BL/6 mice (Figure 7A–D). In line with
these data, frequencies and numbers of TNF-a producing T cells
were increased in mice with selective IL-10 deficiency in T cells
compared to Cre negative littermate controls and C57BL/6 mice
(Figure 7E–J). Likewise, the number of IFN-c+ CD8+ T cells was
higher in the spleens of Il-10fl/flxCD4-Cre+ than in Il-10fl/flxCD4-
Cre2 mice (Figure S5F). However, the percentage and total
number of TNF-a producing antiviral CD4+ and CD8+ T cells
was lower in Il-10fl/flxCD4-Cre+ mice compared to Il-102/2 mice,
underlining the fact that macrophages and potentially also other
cell populations contribute to the overall relevant IL-10 produc-
tion. It should be noted that a slight increase in the viral inoculum
led to increased incidence of viral chronicity in Il-10fl/flxCD4-Cre+
mice while most Il-102/2 mice were still able to clear the infection
(data not shown), suggesting that IL-10 derived from T cells and
myeloid cells act together to exert its full biological activity.
To further assess which CD4+ T cell subpopulation might be
mainly responsible for the IL-10 production, TIGER IL-10
reporter mice were analyzed for GFP expression on day 10 post
infection in TFH and TH1 cells using PSGL1 and Ly6C as
surrogate markers (with PSGL1+ Ly6C+ CD4+ T cells representing
TH1 cells and PSGL1
2 Ly6C2 cells representing TFH cells; Figure
S7A–F). GFP+ cells could be detected in both subpopulations.
Likewise, GFP expression could be detected in a subpopulation of
Neuropilin+ natural Tregs. However, the biggest increase compared
to the naı¨ve situation could be detected in Neuropilin2 induced
Tregs (Figure S7G–I). The finding that induced Tregs as opposed to
TH1 cells are probably responsible for the majority of the CD4
+ T
cell derived IL-10 is supported by the finding that only very few
IFN-c+ CD4+ T cells co-produced IL-10 (Figure S7J–K).
IL-10 Source Supporting LCMV Chronicity
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Discussion
Several cell populations are capable of producing IL-10 [10,38].
DCs, B cells, macrophages, CD4+ and CD8+ T cells were
previously shown to produce IL-10 after LCMV infection
[2,3,22,24]. However, data on functional consequences of IL-10
deficiency in defined cell types were lacking so far. In agreement
with previous studies [2,3,22,24] we demonstrate here that DCs, B
Figure 3. B cell derived IL-10 does not promote viral chronicity and T cell exhaustion. Il-102/2, Il-10fl/flxCD19-Cre+, Il-10fl/flxCD19-Cre2 and
C57BL/6 mice were infected with Clone 13. Virus titers were determined in (A) spleen, (B) kidney, (C) liver and (D) lung on day 10 or day 12 post
infection. (A–D) Each symbol represents one individual mouse; the solid lines represent the geometric means, the dashed line the detection limit.
Statistical significance was determined with the Mann-Whitney test. (E and H) TNF-a production by CD8+ T cells in lung mononuclear cells was
determined after 5 hours stimulation with the peptide gp33. TNF-a secretion by CD4+ T cells in (F and I) lung mononuclear cells and (G and J)
splenocytes was determined after 5 hours stimulation with the peptide p13. Mean and standard deviation of the (E–G) percentages and (H–J) total
numbers are shown. A summary of all mice from three independent experiments with 4–5 mice per group is depicted. Statistical significance was
determined with unpaired 2-tailed Student’s t test. n.s.: not significant; * p,0.05; ** p,0.01; *** p,0.001; *** p,0.0001.
doi:10.1371/journal.ppat.1003735.g003
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cells, macrophages, CD4+ and CD8+ T cells, but also neutrophils,
NK cells and NKT cells produce IL-10 in the early phase of high
dose LCMV Clone 13 infection. These diverse IL-10 producing
cell types potentially all play important and distinct roles in
suppressing the host’s immune response. However, we clearly
show that myeloid and T cell derived IL-10 is critical in promoting
viral chronicity and T cell exhaustion, while IL-10 derived from
other sources, including DCs, only contributes marginally - if at all
- to the suppression of the antiviral immune response. Since
depletion of monocytes/macrophages but not neutrophils led to
Figure 4. NK cell derived IL-10 does not promote viral chronicity and T cell exhaustion. Il-102/2, Il-10fl/flxNcr1-Cre+, Il-10fl/flxNcr1-Cre2 and
C57BL/6 mice were infected with Clone 13. Virus titers were determined in (A) spleen, (B) kidney, (C) liver and (D) lung on day 12 post infection. (A–D)
Each symbol represents one individual mouse; the solid lines represent the geometric means, the dashed line the detection limit. Statistical
significance was determined with the Mann-Whitney test. (E and H) TNF-a production by CD8+ T cells in lung mononuclear cells was determined after
5 hours stimulation with the peptide gp33. TNF-a secretion by CD4+ T cells in (F and I) lung mononuclear cells and (G and J) splenocytes was
determined after 5 hours stimulation with the peptide p13. Mean and standard deviation of the (E–G) percentages and (H–J) total numbers are
shown. A summary of all mice from three independent experiments with 3–10 mice per group is depicted. Statistical significance was determined
with unpaired 2-tailed Student’s t test. n.s.: not significant; * p,0.05; ** p,0.01; *** p,0.001; *** p,0.0001.
doi:10.1371/journal.ppat.1003735.g004
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markedly reduced IL-10 mRNA levels, we conclude that
monocyte/macrophage derived IL-10 accounts for the reduced
virus titer and increased cytokine production by antiviral T cells
occurring in the myeloid cell specific IL-10 knockout mice.
IL-10 drives viral persistence in a number of chronic infections.
Elevated IL-10 levels were found to correlate with HIV replication
in humans and chronicity during HCV and HBV infection [4,5,6].
Likewise, disruption of IL-10 receptor signaling enhances CD8+
effector functions of T cells isolated from HIV, HCV and HBV
infected individuals [6,7,8,9] like after LCMV infection [2,3].
The dominant IL-10 producing cell population varies with
different infections, likely reflecting differences in pathogen-
specific responses and tissue-specific immune regulation. Usually,
IL-10 is produced by multiple cell populations [10]. During HIV
infection, IL-10 production by T cells, B cells, NK cells and
monocytes was reported [4] with monocytes/macrophages being
the subset producing highest levels of IL-10 in the peripheral blood
[39,40,41]. In contrast, B cell derived IL-10 is important during
HBV infection [6]. During murine cytomegalovirus (MCMV)
infection, IL-10 can be produced by CD4+ T cells, B cells,
inflammatory macrophages, dendritic cells and NK cells
[19,35,42,43]. The biologically relevant in vivo sources of IL-10
in MCMV infection were identified as CD11c+ cells and to some
extent macrophages. IL-10 from these cellular sources led to the
suppression of NK/DC cross-talk and consequently to curtailed
CD4+ T cell priming, thereby promoting prolonged lytic MCMV
[19]. In addition, B cell produced IL-10 was shown to suppress the
CD8+ T cell response in the spleen during MCMV infection [35].
During Leishmania major infection anti-IL-10R treatment leads to
sterile cure of infection with complete elimination of the parasite.
In this infection model, CD4+ and CD8+ T cell derived IL-10
plays an essential role for the establishment of pathogen
persistence [44]. Thus, the different importance of certain cell
populations serving as IL-10 source might depend on the specific
tissue, the cell population affected and the time after infection.
It was recently shown that myeloid suppressor cells inhibit
CD8+ T cell proliferation during chronic LCMV infection [45].
However, the fact that in vitro co-cultivated myeloid suppressor
cells could still inhibit CD8+ T cell proliferation in presence of an
anti-IL-10R antibody [45] renders it rather unlikely that myeloid
Figure 5. CD11c+ cell derived IL-10 does not promote viral chronicity and T cell exhaustion. Il-102/2, Il-10fl/flxCD11c-Cre+, Il-10fl/flxCD11c-
Cre2 and C57BL/6 mice were infected with Clone 13. Virus titers were determined in (A) spleen, (B) kidney, (C) liver and (D) lung on day 10 or 12 post
infection. (A–D) Each symbol represents one individual mouse; the solid lines represent the geometric means, the dashed line the detection limit.
Statistical significance was determined with the Mann-Whitney test. (E and G) TNF-a production by CD8+ T cells in lung mononuclear cells was
determined after 5 hours stimulation with the peptide gp33. TNF-a secretion by CD4+ T cells in (F and H) lung mononuclear cells was determined
after 5 hours stimulation with the peptide p13. Mean and standard deviation of (E and F) the percentages and (G and H) total numbers are shown. A
summary of all mice from three independent experiments with 2–8 mice per group is depicted. Statistical significance was determined with unpaired
2-tailed Student’s t test. n.s.: not significant; * p,0.05; ** p,0.01; *** p,0.001; *** p,0.0001.
doi:10.1371/journal.ppat.1003735.g005
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Figure 6. Mononuclear cells are a biologically relevant IL-10 source. Il-102/2, Il-10fl/flxLysM-Cre+, Il-10fl/flxLysM-Cre2 and C57BL/6 mice were
infected with Clone 13. Virus titers were determined in (A) spleen, (B) kidney, (C) liver and (D) lung on day 11 or 12 post infection. Each symbol
represents one individual mouse; the solid lines represent the geometric means, the dashed line the detection limit. The numbers indicate how many
mice per total mice exhibited virus titers below 103 in spleen and kidney, 56103 in liver and 104 in lung. Statistical significance was determined with
the Mann-Whitney test. (E and H) TNF-a production by CD8+ T cells in lung mononuclear cells was determined after 5 hours stimulation with the
peptide gp33. TNF-a secretion by CD4+ T cells in (F and I) lung mononuclear cells and (G and J) splenocytes was determined after 5 hours stimulation
with the peptide p13. Mean and standard deviation of the (E–G) percentages and (H–J) total numbers are shown. Statistical significance was
determined with unpaired 2-tailed Student’s t test. A summary of all mice from four independent experiments with 2–8 mice per group is depicted.
n.s.: not significant; * p,0.05; ** p,0.01; *** p,0.001; *** p,0.0001.
doi:10.1371/journal.ppat.1003735.g006
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suppressor cells are a relevant source of IL-10, assuming that IL-10
acts directly on the CD8+ T cells.
CD4+ T cell depletion led to a decrease in the overall IL-10
mRNA levels on day 5 post infection with LCMV while depletion
of CD8+ T cells had no effect (Figure 2). Therefore, it is likely that
CD4+ T cell derived IL-10 is more important than CD8+ T cell
derived IL-10. IL-10 was initially identified as TH2 cytokine [46],
but can also be produced by TH1, TH17, TFH, natural and
Figure 7. T cells are a biologically relevant IL-10 source. Il-102/2, Il-10fl/flxCD4-Cre+, Il-10fl/flxCD4-Cre2 and C57BL/6 mice were infected with
Clone 13. Virus titers were determined in (A) spleen, (B) kidney, (C) liver and (D) lung on day 10 or 12 post infection. Each symbol represents one
individual mouse; the solid lines represent the geometric means, the dashed line the detection limit. The numbers indicate how many mice per total
mice exhibited virus titers below 103 in spleen and kidney, 56103 in liver and 104 in lung. Statistical significance was determined with the Mann-
Whitney test. (E and H) TNF-a production by CD8+ T cells in lung mononuclear cells was determined after 5 hours stimulation with the peptide gp33.
TNF-a secretion by CD4+ T cells in (F and I) lung mononuclear cells and (G and J) splenocytes was determined after 5 hours stimulation with the
peptide p13. Mean and standard deviation of the (E–G) percentages and (H–J) total numbers are shown. Statistical significance was determined with
unpaired 2-tailed Student’s t test. A summary of all mice from two independent experiments with 3–8 mice per group is depicted. * p,0.05; **
p,0.01; *** p,0.001; *** p,0.0001.
doi:10.1371/journal.ppat.1003735.g007
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induced Tregs [47]. As aCD25 depletion did not decrease IL-10
mRNA levels on day 2 post infection, natural Tregs do not seem to
be relevant IL-10 producers during LCMV infection. These data
were supported by the finding that IL-10+ Neuropilin+ natural
Tregs did not accumulate upon infection. In contrast to natural
Tregs, IL-10-producing Neuropilin
2 induced Tregs accumulated by
day 10 after LCMV infection and likely constitute a subpopulation
of CD4+ T cells that is responsible to promote chronicity of the
infection, at least on day 10 post infection when LCMV chronicity
is already established. Accumulation of induced Tregs during
established chronic LCMV infection is in agreement with previous
studies [48,49].
Interestingly, the depletion of monocytes/macrophages de-
creased IL-10 mRNA levels on days 2 and 5 post infection while
CD4+ T cell depletion led to reduced concentrations of IL-10
mRNA only on day 5. This implies a cooperation of macrophages
and CD4+ T cells in a way that the macrophages provide a first
wave of IL-10 until, in a second wave, different subtypes of CD4+
T cells (TH1, TFH, natural Tregs and induced Tregs with induced
Tregs exhibiting the highest percentage of IL-10 producing cells)
start to significantly contribute to the overall IL-10 production.
Together with the fact that all analyzed CD4+ T cell subpopu-
lations contribute to IL-10 production, it seems as if multiple cell
types share the task of IL-10 secretion in a time-dependent
manner. It is possible that IL-10 production by monocytes/
macrophages is preceded by a first wave of IL-10 production by
NK cells. However, absence of NK cell derived IL-10 did not
promote control of high dose LCMV infection, suggesting that IL-
10 production by monocytes/macrophages plays a more dominant
role. It should be noted, however, that the NK cell-specific Il-10
deletion efficacy was only 63% (Figure S6 and [50]), but in
combination with the observation that NK cell depletion did not
lead to an overall reduction in IL-10 mRNA on day 2 post
infection it is rather unlikely that NK cell produced IL-10 plays a
decisive role in promoting LCMV chronicity.
The observation that dendritic cells produce IL-10 and that the
IL-10 mRNA levels decreased dramatically in absence of CD11c+
cells (Figure 2C) is consistent with the finding that Il-10fl/flxCD11c-
Cre mice expressed considerably less IL-10 (Figure 2G and [24]).
Importantly and to some extend surprisingly, we extend this
observation by showing that IL-10 produced by CD11c+ cells lacks
functional consequences with respect to antiviral T cell function or
the establishment of viral chronicity (Figure 5).
It is likely that the precise anatomical localization and kinetics of
the IL-10 secreting cells in relation to the responding cell is of
considerable importance. This would be one possible explanation
for the observation that IL-10 produced by CD11c+ cells does not
influence the outcome of the infection even though IL-10
promoter activity could be detected in DCs of IL-10 reporter
mice and even though depletion of CD11c+ cells dramatically
decreased the overall amount of IL-10 mRNA. On the other hand,
post-transcriptional regulation of IL-10 may vary in different cell
types, such that quantitative differences evidenced by mRNA
analyses might not translate to the protein level [51,52].
One potential caveat of IL-10 mRNA analysis after in vivo
depletion of certain cell populations for several days into LCMV
infection is that the absence of specific cell types may alter
virus titers which might in turn affect the IL-10 production
by other cells types. In addition, depletion of CD11c+ cells by
DT administration in CD11c-DTR+ mice was shown to cause
neutrophilia [53]. So, if neutrophils contributed to IL-10 pro-
duction significantly, their increased abundance might have
masked the decrease in IL-10 mRNA levels in diphtheria toxin
treated CD11c-DTR mice.
Our data do not permit a conclusion on whether the more
potent antiviral T cell responses observed in absence of T cell
or myeloid-derived IL-10 are a cause or a consequence of
the concomitantly reduced virus titers, but they underscore
an important role of IL-10 in shaping the mutual relationship
between prolonged high antigen load and decreased T cell
function [26]. It has to be noted that only a defined LCMV
inoculum is controlled in the T specific IL-10 knockout mice,
while a wider range of inocula is controlled in full IL-10 deficient
mice. This is likely one reason why the full IL-10 knockout mice
show more robust T cell responses compared to the cell-specific
knockout mice, yet these small increases might be sufficient under
these experimental settings to allow for virus control.
At present it is unclear on which cell types the T cell or myeloid
cell derived IL-10 acts to promote viral chronicity but it is likely
that multiple immune cell subsets will be targeted. It was recently
shown that splenic DCs treated in vitro with type I IFN produce IL-
10 [24] and that anti-IFNR1 blockade led to reduced numbers of
IL-10+ PD-L1+ immunoregulatory DCs which in turn stimulated
elevated numbers of IFN-c+ CD4+ T cells and a decrease in viral
titers [54]. It is likely that type I IFN also directly induces IL-10
production in macrophages at the early time points after infection.
However, as the amounts of IFN decline at later time points [55],
this might indicate that CD4+ T cell derived IL-10 is induced by
other mechanisms.
In this context we have measured type I IFNs in the serum of
C57BL/6 and Il-102/2 mice and we have observed increased
concentrations of type I IFN in Il-102/2 mice on day 3 post
infection (data not shown). As Type I IFNs are an essential signal 3
in LCMV to drive T cell expansion [56,57] and effector cell
differentiation [58], it is possible that increased peak levels of type I
IFNs might contribute to more effective T cell responses which in
turn would accelerate virus control. It is also possible that
increased levels of type I IFNs in Il-102/2 mice might have a
direct effect on LCMV control, but this is rather unlikely as we do
not see any changes in viral load in the first 5 days post infection.
As we determined that IL-10 has to act within the first 2 days it
is very likely that initially innate immune cells or non-hematopoi-
etic cells are targeted by IL-10. Indeed, we have preliminary data
that IL-10 does not directly act on CD4+ or CD8+ T cells and on
DCs (data nor shown). The innate target cells could be
macrophages themselves (being infected by LCMV) which are
modulated by IL-10 such that they would better sustain viral
replication, potentially by inhibition of NO production as it was
shown for parasite infection [59] or by inhibition of TNF-a and
IFN-c production [60]. We believe that a direct effect of IL-10 on
virus production is rather unlikely as we have seen in our in vivo
kinetics of viral loads that differences between C57BL/6 and
Il-102/2 mice only become apparent after day 6 of infection
(Fig. 1).
Alternatively, NK cells might be possible IL-10 target cells as
they are mainly situated in the red pulp of the spleen where they
might be targeted by macrophage-secreted IL-10. In MCMV
infection it has been shown that NK cells are over-activated in
absence of IL-10 and are undergoing increased levels of activation-
induced cell death [43]. As it has been shown in the LCMV system
that activated NK cells can reduce the number of activated virus-
specific CD4+ T cells [61], it is conceivable that potentially
reduced numbers of NK cells in the absence of IL-10 would
translate into better preserved virus-specific CD4+ (and CD8+) T
cell responses.
With respect to the secondary requirement of CD4+ T cell
derived IL-10 driving viral chronicity we hypothesize that by day
4–5 post infection, activated CD4+ T cells will not only be in
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secondary lymphoid organs but also in (infected) peripheral tissues
where their IL-10 secretion might affect local immune control.
Based on our observation that IL-10 does not directly act on T
cells and based on additional observations that the per cell killing
efficiency of CD8+ T cells (when using optimally peptide-loaded
APCs) is not altered in presence or absence of IL-10 (data not
shown), we postulate that either the increased frequencies of T
cells in peripheral tissues lead to better virus control or that in
addition presence of (CD4+ T cell secreted) IL-10 would impact on
the antigen presentation on infected cells. IL-10 is known to down-
modulate MHC expression and it could thereby reduce sensitivity
towards LCMV infected cells.
In summary, our data clearly indicate a non-redundant role of
T cell and myeloid cell derived IL-10 in facilitating viral chronicity
and T cell exhaustion after LCMV Clone 13 infection as opposed
to DCs, which were so far proclaimed to exert this function.
Materials and Methods
Virus and viral peptides
LCMV Clone 13 was propagated and titrated as described [62].
The viral peptides gp33–41 (gp33; KAVYNFATM), np396–404
(np396; FQPQNGQFI) and gp61–80 (p13; LNGPDIYKG-
VYQFKSVEFD) were purchased from NeoMPS (Strasbourg,
France).
Mice
Animal experiments were performed according to the guidelines
of the animal experimentation law (SR 455.163; TVV) of the
Swiss Federal Government. The protocol was approved by the
Cantonal Veterinary Office (animal experimentation number
146/2008 and 127/2011).
Ncr1-Cre mice [50] were crossed to Il-10fl/fl mice [37] yielding Il-
10fl/flxNcr1-Cre mice.
C57BL/6 (Janvier Elevage, Le Genest Staint Isle, France), Il-
10fl/flxCD4-Cre [37], Il-10fl/flxLysM-Cre [36], Il-10fl/flxCD11c-Cre
[24], Il-10fl/flxCD19-Cre [35], Il-10fl/flxM5-Cre [31], Il-102/2 [63],
TIGER [64] and CD11c-DTR/GFP [29] mice were kept under
specific pathogen-free conditions and were intravenously (i.v.)
infected with LCMV Clone 13. Each virus stock was titrated in vivo
and injected at doses that led to a chronic infection in C57BL/6
mice and to reduced virus titers by day 10 to 12 in most of the Il-
102/2 mice (between 36105 and 106 ffu per mouse).
Antibodies and in vivo depletion of cell populations
Antibodies used for flow cytometry were purchased from BD
Pharmingen (Allschwil, Switzerland), Biolegend (LucernaChem,
Luzern, Switzerland) and R&D Systems (Abingdon, England). For
the depletion of neutrophils, mice were i.p. injected with 500 mg
aLy6G (clone 1A8, BioXCell, West Lebanon, NH, USA) on day
-2 and one hour before infection (99.8% reduction in the
percentage of Ly6G+ cells). For the depletion of CD4+ T cells,
mice were i.p. injected with 200 mg aCD4 (YTS 191.1) on day -2
and one hour before infection (depletion efficacy of 97% while the
percentage of CD8+ T cells increased slightly). For the depletion of
B cells, mice were i.p. injected with 250 mg aCD20 (18B12; IgG2a;
[65]) on day -2 and one hour before infection (depletion efficacy of
98% while the percentage of CD8+ T cells and CD4+ T cells
increased compared to mice treated with an isotpye control). For
the depletion of CD8+ T cells, mice were i.p. injected with 200 mg
aCD8 (YTS 169.4) on day -2 and one hour before infection
(depletion efficacy of 99% while the CD4+ T cell population stayed
unaffected). Depletion of NK-like cells was performed by i.p.
administration of 300 mg aNK1.1 (PK136, BioXCell) on days -3
and -1 (depletion efficacy of 96% while the percentage of CD3+
cells was not affected). For the depletion of regulatory CD4+ T
cells mice were i.p. injected with 200 mg of aCD25 (PC-61.5.3,
BioXCell) 3 and 1 day before infection (depletion efficacy of 70%).
For depletion of CD11c+ cells, CD11c-DTR+ and CD11c-DTR2
mice were i.p. treated with 200 ng diphtheria toxin (Sigma-
Aldrich, Buchs, Switzerland) on days -2, -1 and 0 (depletion
efficacy of 95% while the percentage of B cells was not affected).
For depletion of monocytes/macrophages mice were i.p. treated
with liposomes containing 1 mg clodronate [27] or equal amounts
of empty control liposomes on days -7, -5, -2 and 0 (depletion
efficacy of 96% while the percentage of B cells and T cells was not
affected). The depleted mice were analyzed on day 2 post
infection. When analyzed on day 5 post infection, the depleting
agent was continuously administered every second to third day.
Isolation and stimulation of lymphocytes and flow
cytometry
Splenocytes and mononuclear cells from lungs were prepared,
stimulated and stained as previously described [26]. Phorbol
12-myristate 13-acetate (PMA) and Ionomycin were purchased
from Sigma and used at 50 ng/ml and 500 ng/ml, respectively.
Multiparameter flow cytometric analysis was performed using a
FACS LSRII flow cytometer (BD Biosciences, Allschwil, Switzer-
land) with FACSDiva software. Analysis was performed using
FlowJo software (Tree Star, San Carlos, CA). Sorting was
performed using a FACS Aria flow cytometer (BD Biosciences,
Allschwil, Switzerland). The sorted cell populations were defined
as follows: CD4+ T cells: CD4+ CD252; CD25+ CD4+ T cells:
CD4+ CD25+; CD8+ T cells: CD8+ CD42; B cells: CD42 CD19+;
pDCs: B220+ PDCA-1+ Ly6C+; DCs: CD11c+ I-A/I-E+; CD82
DCs: CD11c+ I-A/I-E+ CD82; CD8+ DCs: CD11c+ I-A/I-E+
CD8+; inflammatory monocytes: CD11b+ Ly6C+ Ly6G2; neutro-
phils: CD11b+ Ly6C2 Ly6G+; macrophages: CD11bint F4/80+;
NKT cells: CD3+ NK1.1+; NK cells: CD32 NK1.1+.
Enrichment of NK cells and DCs and Southern blot
NK cells were isolated from splenocytes on day 7 after i.p.
infection with 56104 pfu MCMV Smith by magnetic negative
selection of CD3+ and CD19+ cells and subsequent FACS sorting
of CD32 NK1.1+ cells. DCs were isolated from splenocytes on day
7 after s.c. injection with 106 B16-Flt3L cells by magnetic negative
selection of CD3+ and CD19+ cells and subsequent FACS sorting
of CD11c+ MHCII+ cells. Southern Blot was performed as
described [37].
RNA isolation, reverse transcription and IL-10 qPCR
Total RNA was isolated with Trizol (Invitrogen, Basel,
Switzerland) according to the manufacturer’s instructions. For
isolation of RNA from whole organs, the organ was homogenized
with a stainless steel bead for 1.5 min at 25 Hz in a Qiagen Tissue
Lyser. 1 mg of RNA was reverse transcribed with M-MLV Reverse
Transcriptase RNase, H Minus (Promega, Du¨bendorf, Switzer-
land). Real-time PCR was performed using a Rotorgene 3000
instrument (Corbett Research, Eight Miles Plains, Australia) to
measure SYBR green (Sensi Mix, R&D Systems) incorporation.
The following primer sets were used: IL-10: 59-ATGCTGC-
CTGCTCTTACTGACTG-39 and 59-CCCAAGTAACCCT-
TAAATCCTGC-39 [66]; b-actin: 59-CCCTGAAGTACCC-
CATTGAAC-39 and 59-CTTTTCACGGTTGGCCTTAG-39.
The amount of IL-10 mRNA was normalized to b-actin RNA
levels for each sample and was expressed relative to the levels of
uninfected control mice.
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Statistical analysis
The two-tailed unpaired t test was applied for statistical analysis
when the distribution was Gaussian. Otherwise, the Mann-
Whitney test was performed. * p,0.05; ** p,0.01; ***p,0.001;
**** p,0.0001; n.s. not significant.
Supporting Information
Figure S1 Kinetics of virus titers in presence and absence of IL-
10 and IL-10 mRNA expression levels early after LCMV Clone 13
infection.
(TIF)
Figure S2 IL-10-GFP reporter expression on days 2 and 5 post
infection.
(TIF)
Figure S3 Mast cell derived IL-10 does not promote viral
chronicity and T cell exhaustion.
(TIF)
Figure S4 B cell derived IL-10 does not promote viral chronicity
and T cell exhaustion.
(TIF)
Figure S5 IFN-c production in absence of mast cell-, B cell-, NK
cell-, DC-, myeloid cell- and T cell-derived IL-10.
(TIF)
Figure S6 Specific deletion of the Il-10 gene in NK cells of Il-
10fl/flxNcr1-Cre and in DCs of Il-10fl/flxCD11c-Cre mice.
(TIF)




We thank Nathalie Oetiker and Franziska Wagen for excellent technical
assistance and the members of the Oxenius group for fruitful discussions.
We thank Christopher Wilson, University of Washington, for provision of
CD4-Cre mice, and the MGC foundation, Munich, Germany for provision
of the CD19-Cre mice [67].
Author Contributions
Conceived and designed the experiments: KR AO. Performed the
experiments: KR GP RB. Analyzed the data: KR GP RB AO. Contributed
reagents/materials/analysis tools: RAS VS RD MK RAF AR. Wrote the
paper: KR AO.
References
1. Frebel H, Richter K, Oxenius A (2010) How chronic viral infections impact on
antigen-specific T-cell responses. Eur J Immunol 40: 654–663.
2. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, et al. (2006)
Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12:
1301–1309.
3. Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, et al. (2006)
Resolution of a chronic viral infection after interleukin-10 receptor blockade.
J Exp Med 203: 2461–2472.
4. Brockman MA, Kwon DS, Tighe DP, Pavlik DF, Rosato PC, et al. (2009) IL-10
is up-regulated in multiple cell types during viremic HIV infection and reversibly
inhibits virus-specific T cells. Blood 114: 346–356.
5. Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, et al. (2011) Early IL-
10 predominant responses are associated with progression to chronic hepatitis C
virus infection in injecting drug users. J Viral Hepat 18: 549–561.
6. Das A, Ellis G, Pallant C, Lopes AR, Khanna P, et al. (2012) IL-10-producing
regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.
J Immunol 189: 3925–3935.
7. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, et al. (1994) Role of
interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected
with the human immunodeficiency virus. J Clin Invest 93: 768–775.
8. Landay AL, Clerici M, Hashemi F, Kessler H, Berzofsky JA, et al. (1996) In vitro
restoration of T cell immune function in human immunodeficiency virus-positive
persons: effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis 173: 1085–
1091.
9. Rigopoulou EI, Abbott WG, Haigh P, Naoumov NV (2005) Blocking of
interleukin-10 receptor–a novel approach to stimulate T-helper cell type 1
responses to hepatitis C virus. Clin Immunol 117: 57–64.
10. Wilson EB, Brooks DG (2011) The role of IL-10 in regulating immunity to
persistent viral infections. Curr Top Microbiol Immunol 350: 39–65.
11. Couper KN, Blount DG, Riley EM (2008) IL-10: the master regulator of
immunity to infection. J Immunol 180: 5771–5777.
12. Slobedman B, Barry PA, Spencer JV, Avdic S, Abendroth A (2009) Virus-
encoded homologs of cellular interleukin-10 and their control of host immune
function. J Virol 83: 9618–9629.
13. Chang WL, Barry PA (2010) Attenuation of innate immunity by cytomegalo-
virus IL-10 establishes a long-term deficit of adaptive antiviral immunity. Proc
Natl Acad Sci U S A 107: 22647–22652.
14. Paladino N, Fainboim H, Theiler G, Schroder T, Munoz AE, et al. (2006)
Gender susceptibility to chronic hepatitis C virus infection associated with
interleukin 10 promoter polymorphism. J Virol 80: 9144–9150.
15. Helminen M, Lahdenpohja N, Hurme M (1999) Polymorphism of the
interleukin-10 gene is associated with susceptibility to Epstein-Barr virus
infection. J Infect Dis 180: 496–499.
16. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, et al. (2006) Association
between chronic hepatitis B virus infection and interleukin-10, tumor necrosis
factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol 21: 1163–
1169.
17. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, et al. (2003) Interleukin 10
haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol
Genet 12: 901–906.
18. Shin HD, Winkler C, Stephens JC, Bream J, Young H, et al. (2000) Genetic
restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc
Natl Acad Sci U S A 97: 14467–14472.
19. Mandaric S, Walton SM, Rulicke T, Richter K, Girard-Madoux MJ, et al.
(2012) IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-
specific CD4 T cells and prolonged MCMV persistence. PLoS Pathog 8:
e1002846.
20. Tang-Feldman YJ, Lochhead GR, Lochhead SR, Yu C, Pomeroy C (2011)
Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases
liver pathology without altering viral replication in murine cytomegalovirus
(MCMV)-infected IL-10 knockout mice. Inflamm Res 60: 233–243.
21. Lin MT, Hinton DR, Parra B, Stohlman SA, van der Veen RC (1998) The role
of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis.
Virology 245: 270–280.
22. Brooks DG, Teyton L, Oldstone MB, McGavern DB (2005) Intrinsic functional
dysregulation of CD4 T cells occurs rapidly following persistent viral infection.
J Virol 79: 10514–10527.
23. Wilson EB, Kidani Y, Elsaesser H, Barnard J, Raff L, et al. (2012) Emergence of
distinct multiarmed immunoregulatory antigen-presenting cells during persistent
viral infection. Cell Host Microbe 11: 481–491.
24. Ng CT, Oldstone MB (2012) Infected CD8alpha- dendritic cells are the
predominant source of IL-10 during establishment of persistent viral infection.
Proc Natl Acad Sci U S A 109: 14116–14121.
25. Frebel H, Oxenius A (2013) The risks of targeting co-inhibitory pathways to
modulate pathogen-directed T cell responses. Trends Immunol 34: 193–199.
26. Richter K, Brocker T, Oxenius A (2012) Antigen amount dictates CD8+ T-cell
exhaustion during chronic viral infection irrespective of the type of antigen
presenting cell. Eur J Immunol 42: 2290–2304.
27. Seiler P, Aichele P, Odermatt B, Hengartner H, Zinkernagel RM, et al. (1997)
Crucial role of marginal zone macrophages and marginal zone metallophils in
the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol
27: 2626–2633.
28. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer
K, et al. (2006) Clodronate-liposome-mediated depletion of tumour-associated
macrophages: a new and highly effective antiangiogenic therapy approach.
Br J Cancer 95: 272–281.
29. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, et al. (2002) In vivo
depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by
exogenous cell-associated antigens. Immunity 17: 211–220.
30. Probst HC, van den Broek M (2005) Priming of CTLs by lymphocytic
choriomeningitis virus depends on dendritic cells. J Immunol 174: 3920–3924.
31. Dudeck A, Dudeck J, Scholten J, Petzold A, Surianarayanan S, et al. (2011) Mast
cells are key promoters of contact allergy that mediate the adjuvant effects of
haptens. Immunity 34: 973–984.
32. Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD, Wherry EJ (2011)
A role for the chemokine RANTES in regulating CD8 T cell responses during
chronic viral infection. PLoS Pathog 7: e1002098.
33. Penaloza-MacMaster P, Ur Rasheed A, Iyer SS, Yagita H, Blazar BR, et al.
(2011) Opposing effects of CD70 costimulation during acute and chronic
lymphocytic choriomeningitis virus infection of mice. J Virol 85: 6168–6174.
IL-10 Source Supporting LCMV Chronicity
PLOS Pathogens | www.plospathogens.org 13 November 2013 | Volume 9 | Issue 11 | e1003735
34. Richter K, Perriard G, Oxenius A (2013) Reversal of chronic to resolved
infection by IL-10 blockade is LCMV strain dependent. Eur J Immunol 43: 649–
654.
35. Madan R, Demircik F, Surianarayanan S, Allen JL, Divanovic S, et al. (2009)
Nonredundant roles for B cell-derived IL-10 in immune counter-regulation.
J Immunol 183: 2312–2320.
36. Siewe L, Bollati-Fogolin M, Wickenhauser C, Krieg T, Muller W, et al. (2006)
Interleukin-10 derived from macrophages and/or neutrophils regulates the
inflammatory response to LPS but not the response to CpG DNA. Eur J Immunol
36: 3248–3255.
37. Roers A, Siewe L, Strittmatter E, Deckert M, Schluter D, et al. (2004) T cell-
specific inactivation of the interleukin 10 gene in mice results in enhanced T cell
responses but normal innate responses to lipopolysaccharide or skin irritation.
J Exp Med 200: 1289–1297.
38. Saraiva M, O’Garra A (2010) The regulation of IL-10 production by immune
cells. Nat Rev Immunol 10: 170–181.
39. Hagiwara E, Abbasi F, Mor G, Ishigatsubo Y, Klinman DM (1995) Phenotype
and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in
human peripheral blood. Cytokine 7: 815–822.
40. Kumar A, Angel JB, Daftarian MP, Parato K, Cameron WD, et al. (1998)
Differential production of IL-10 by T cells and monocytes of HIV-infected
individuals: association of IL-10 production with CD28-mediated immune
responsiveness. Clin Exp Immunol 114: 78–86.
41. Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, et al. (2010) Programmed
death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell
activation during HIV infection. Nat Med 16: 452–459.
42. Humphreys IR, de Trez C, Kinkade A, Benedict CA, Croft M, et al. (2007)
Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary
glands. J Exp Med 204: 1217–1225.
43. Stacey MA, Marsden M, Wang EC, Wilkinson GW, Humphreys IR (2011) IL-
10 restricts activation-induced death of NK cells during acute murine
cytomegalovirus infection. J Immunol 187: 2944–2952.
44. Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, et al. (2001) The
role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after
healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile
cure. J Exp Med 194: 1497–1506.
45. Norris BA, Uebelhoer LS, Nakaya HI, Price AA, Grakoui A, et al. (2013)
Chronic but Not Acute Virus Infection Induces Sustained Expansion of Myeloid
Suppressor Cell Numbers that Inhibit Viral-Specific T Cell Immunity.
Immunity 38: 309–321.
46. Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper
cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1
clones. J Exp Med 170: 2081–2095.
47. Maynard CL, Weaver CT (2008) Diversity in the contribution of interleukin-10
to T-cell-mediated immune regulation. Immunol Rev 226: 219–233.
48. Punkosdy GA, Blain M, Glass DD, Lozano MM, O’Mara L, et al. (2011)
Regulatory T-cell expansion during chronic viral infection is dependent on
endogenous retroviral superantigens. Proc Natl Acad Sci U S A 108: 3677–3682.
49. Schmitz I, Schneider C, Frohlich A, Frebel H, Christ D, et al. (2013) IL-21
restricts virus-driven Treg cell expansion in chronic LCMV infection. PLoS
Pathog 9: e1003362.
50. Eckelhart E, Warsch W, Zebedin E, Simma O, Stoiber D, et al. (2011) A novel
Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and
development. Blood 117: 1565–1573.
51. Powell MJ, Thompson SA, Tone Y, Waldmann H, Tone M (2000)
Posttranscriptional regulation of IL-10 gene expression through sequences in
the 39-untranslated region. J Immunol 165: 292–296.
52. Maroof A, Beattie L, Zubairi S, Svensson M, Stager S, et al. (2008)
Posttranscriptional regulation of II10 gene expression allows natural killer cells
to express immunoregulatory function. Immunity 29: 295–305.
53. Tittel AP, Heuser C, Ohliger C, Llanto C, Yona S, et al. (2012) Functionally
relevant neutrophilia in CD11c diphtheria toxin receptor transgenic mice. Nat
Methods 9: 385–390.
54. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, et al. (2013)
Blockade of chronic type I interferon signaling to control persistent LCMV
infection. Science 340: 202–207.
55. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, et al. (2013) Persistent
LCMV infection is controlled by blockade of type I interferon signaling. Science
340: 207–211.
56. Aichele P, Unsoeld H, Koschella M, Schweier O, Kalinke U, et al. (2006) CD8
T cells specific for lymphocytic choriomeningitis virus require type I IFN
receptor for clonal expansion. J Immunol 176: 4525–4529.
57. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K (2005)
Type I interferons act directly on CD8 T cells to allow clonal expansion and
memory formation in response to viral infection. J Exp Med 202: 637–650.
58. Wiesel M, Crouse J, Bedenikovic G, Sutherland A, Joller N, et al. (2012) Type-I
IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
Eur J Immunol 42: 320–329.
59. Gazzinelli RT, Oswald IP, James SL, Sher A (1992) IL-10 inhibits parasite
killing and nitrogen oxide production by IFN-gamma-activated macrophages.
J Immunol 148: 1792–1796.
60. O’Farrell AM, Liu Y, Moore KW, Mui AL (1998) IL-10 inhibits macrophage
activation and proliferation by distinct signaling mechanisms: evidence for Stat3-
dependent and -independent pathways. EMBO J 17: 1006–1018.
61. Waggoner SN, Cornberg M, Selin LK, Welsh RM (2012) Natural killer cells act
as rheostats modulating antiviral T cells. Nature 481: 394–398.
62. Richter K, Agnellini P, Oxenius A (2010) On the role of the inhibitory receptor
LAG-3 in acute and chronic LCMV infection. Int Immunol 22: 13–23.
63. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-
deficient mice develop chronic enterocolitis. Cell 75: 263–274.
64. Kamanaka M, Kim ST, Wan YY, Sutterwala FS, Lara-Tejero M, et al. (2006)
Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-
10 reporter knockin tiger mouse. Immunity 25: 941–952.
65. Hamel K, Doodes P, Cao Y, Wang Y, Martinson J, et al. (2008) Suppression of
proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is
mediated by reduction in autoantibodies and CD4+ T cell reactivity.
J Immunol 180: 4994–5003.
66. Nolte MA, Leibundgut-Landmann S, Joffre O, Reis e Sousa C (2007) Dendritic
cell quiescence during systemic inflammation driven by LPS stimulation of
radioresistant cells in vivo. J Exp Med 204: 1487–1501.
67. Rickert RC, Rajewsky K, Roes J (1995) Impairment of T-cell-dependent B-cell
responses and B-1 cell development in CD19-deficient mice. Nature 376: 352–
355.
IL-10 Source Supporting LCMV Chronicity
PLOS Pathogens | www.plospathogens.org 14 November 2013 | Volume 9 | Issue 11 | e1003735
